Abstract
There has been an increasing interest in addressing the issue of submental fat (SMF)
when it comes to cosmetic medicine. With the rise of social media, video calls, and
the now almost omnipresent accessibility of cameras, there is perhaps now more than
ever an emphasis on the facial image. Although invasive procedures such as liposuction
and neck lift still play a significant role in reducing SMF, the trend toward minimally
invasive methods has finally given rise to a single Food and Drug Administration-approved
injectable that is both safe and effective: ATX-101, also known as Kybella in the
United States.
Keywords
Kybella - submental fat - deoxycholic acid
